Cancer Res Treat.  2012 Dec;44(4):280-280.

Reply to Commentary on "A Case of Erdheim-Chester Disease with Asymptomatic Renal Involvement"

• Lee HJ
• Kim TM

Abstract

No abstract available.

MeSH Terms

Erdheim-Chester Disease

Reference

1. Li Cavoli G. Commentary on "A case of Erdheim-Chester disease with asymptomatic renal involvement". Cancer Res Treat. 2012; 44:279.

2. Kajbaf F, Lalau JD. The criteria for metformin-associated lactic acidosis: the quality of reporting in a large pharmacovigilance database. Diabet Med. 2012; 9. 21. [Epub]. http://dx.doi.org/10.1111/dme.12017 .

3. Lee HJ, Lee KY, Shin DY, Lee YG, Choi SY, Moon KC, et al. A case of Erdheim-Chester disease with asymptomatic renal involvement. Cancer Res Treat. 2012; 44:146–150. PMID: 22802754.

4. Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, Grenier PA, et al. Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. Arthritis Rheum. 2006; 54:3330–3336. PMID: 17009306.

5. Haroche J, Charlotte F, Arnaud L, von Deimling A, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012; 120:2700–2703. PMID: 22879539.